Induction of Malignant Plasma Cell Proliferation by Eosinophils

Tina W. Wong, Hirohito Kita, Curtis A. Hanson, Denise K. Walters, Bonnie K. Arendt, Diane F. Jelinek

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


The biology of the malignant plasma cells (PCs) in multiple myeloma (MM) is highly influenced by the bone marrow (BM) microenvironment in which they reside. More specifically, BM stromal cells (SCs) are known to interact with MM cells to promote MM cell survival and proliferation. By contrast, it is unclear if innate immune cells within this same space also actively participate in the pathology of MM. Our study shows for the first time that eosinophils (Eos) can contribute to the biology of MM by enhancing the proliferation of some malignant PCs. We first demonstrate that PCs and Eos can be found in close proximity in the BM. In culture, Eos were found to augment MM cell proliferation that is predominantly mediated through a soluble factor(s). Fractionation of cell-free supernatants and neutralization studies demonstrated that this activity is independent of Eos-derived microparticles and a proliferation-inducing ligand (APRIL), respectively. Using a multicellular in vitro system designed to resemble the native MM niche, SCs and Eos were shown to have non-redundant roles in their support of MM cell growth. Whereas SCs induce MM cell proliferation predominantly through the secretion of IL-6, Eos stimulate growth of these malignant cells via an IL-6-independent mechanism. Taken together, our study demonstrates for the first time a role for Eos in the pathology of MM and suggests that therapeutic strategies targeting these cells may be beneficial.

Original languageEnglish (US)
Article numbere70554
JournalPloS one
Issue number7
StatePublished - Jul 22 2013

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Induction of Malignant Plasma Cell Proliferation by Eosinophils'. Together they form a unique fingerprint.

Cite this